HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ed Fink Selected Research

splenotritin (TP3)

4/2015Impact of a hypoglycemia reduction bundle and a systems approach to inpatient glycemic management.
1/2009Improved inpatient use of basal insulin, reduced hypoglycemia, and improved glycemic control: effect of structured subcutaneous insulin orders and an insulin management algorithm.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ed Fink Research Topics

Disease

2Hyperglycemia
04/2015 - 01/2009
2Hypoglycemia (Reactive Hypoglycemia)
04/2015 - 01/2009
1Thrombocytopenia (Thrombopenia)
01/2010
1Hemorrhage
01/2010

Drug/Important Bio-Agent (IBA)

2Hypoglycemic Agents (Hypoglycemics)IBA
04/2015 - 01/2009
2splenotritin (TP3)IBA
04/2015 - 01/2009
2Glucose (Dextrose)FDA LinkGeneric
04/2015 - 01/2009
1Blood Glucose (Blood Sugar)IBA
04/2015
1Heparin (Liquaemin)FDA LinkGeneric
01/2010
1Insulin (Novolin)FDA Link
01/2009

Therapy/Procedure

2Glycemic Control
04/2015 - 01/2009
1Critical Care (Surgical Intensive Care)
01/2009